Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

ClinicalTrials.gov ID: NCT03472040

Public ClinicalTrials.gov record NCT03472040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Study to Evaluate the Long-term Safety of Daily Oral BCX7353 in Subjects With Type I and II Hereditary Angioedema

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label study to evaluate the long term safety and effectiveness of oral treatment with BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II Hereditary Angioedema (HAE).

Study identification

NCT ID
NCT03472040
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
BioCryst Pharmaceuticals
Industry
Enrollment
387 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2018 (Actual)
Primary completion
Apr 27, 2022 (Actual)
Completion
Apr 27, 2022 (Actual)
Last update posted
Jun 18, 2023

2018 – 2022

United States locations

U.S. sites
42
U.S. states
29
U.S. cities
42
Facility City State ZIP Site status
Study Center Birmingham Alabama 35209 —
Study Center Scottsdale Arizona 85251 —
Study Center Bentonville Arkansas 72712 —
Study Center Little Rock Arkansas 72205 —
Study Center San Diego California 92123 —
Study Center Walnut Creek California 94598 —
Study Center Centennial Colorado 80112 —
Study Center Colorado Springs Colorado 80907 —
Study Center Wheat Ridge Colorado 80033 —
Study Center Waterbury Connecticut 06708 —
Study Center Tampa Florida 33613 —
Study Center Marietta Georgia 30060 —
Study Center Normal Illinois 61761 —
Study Center Evansville Indiana 47713 —
Study Center Indianapolis Indiana 46202 —
Study Center Overland Park Kansas 66210 —
Study Center Louisville Kentucky 40215 —
Study Center Chevy Chase Maryland 20815 —
Study Center Boston Massachusetts 02114 —
Study Center Ann Arbor Michigan 48106 —
Study Center Grand Rapids Michigan 49506 —
Study Center Rochester Minnesota 55905 —
Study Center Madison Mississippi 39110 —
Study Center St Louis Missouri 63141 —
Study Center Lincoln Nebraska 68505 —
Study Center Charlotte North Carolina 28277 —
Study Center Durham North Carolina 27705 —
Study Center Cincinnati Ohio 45231 —
Study Center Columbus Ohio 43235 —
Study Center Clackamas Oregon 97015 —
Study Center Happy Valley Oregon 97086 —
Study Center Hershey Pennsylvania 17033 —
Study Center East Providence Rhode Island 02914 —
Study Center Greer South Carolina 29651 —
Study Center Austin Texas 78731 —
Study Center Dallas Texas 75231 —
Study Center Irving Texas 75063 —
Study Center San Antonio Texas 78229 —
Study Center Murray Utah 84107 —
Study Center Seattle Washington 98115 —
Study Center Spokane Washington 99202 —
Study Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03472040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03472040 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →